{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:31:34Z","timestamp":1747063894390,"version":"3.37.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,11]]},"DOI":"10.1093\/jnci\/djac006","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T20:10:34Z","timestamp":1642191034000},"page":"483-484","source":"Crossref","is-referenced-by-count":1,"title":["Oral Contraceptives and <i>BRCA<\/i> Cancer: A Balancing Act"],"prefix":"10.1093","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-4218","authenticated-orcid":false,"given":"Joanne","family":"Kotsopoulos","sequence":"first","affiliation":[{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, ON, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"issue":"11","key":"2022041207582362500_djac006-B1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2022041207582362500_djac006-B2","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/jnci\/djab036","article-title":"Endometrial cancer risk in women with germline BRCA1 or BRCA2 mutations: multicenter cohort study","volume":"113","author":"de Jonge","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2022041207582362500_djac006-B3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","article-title":"The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study","volume":"130","author":"Segev","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2 Suppl","key":"2022041207582362500_djac006-B4","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1067\/mob.2001.117417","article-title":"Combined oral hormone replacement therapy formulations","volume":"185","author":"Mattox","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2022041207582362500_djac006-B5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jogc.2016.10.005","article-title":"No. 329-Canadian Contraception Consensus Part 4 of 4 chapter 9: combined hormonal contraception","volume":"39","author":"Black","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"2022041207582362500_djac006-B6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1076029616683802","article-title":"Oral contraceptives and HRT risk of thrombosis","volume":"24","author":"Gialeraki","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"2022041207582362500_djac006-B7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"2022041207582362500_djac006-B8","doi-asserted-by":"publisher","first-page":"pky023","DOI":"10.1093\/jncics\/pky023","article-title":"Oral contraceptive use and breast cancer risk: retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study","volume":"2","author":"Schrijver","year":"2018","journal-title":"JNCI Cancer Spectr"},{"issue":"3","key":"2022041207582362500_djac006-B9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10549-013-2823-4","article-title":"Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers","volume":"143","author":"Kotsopoulos","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"9017","key":"2022041207582362500_djac006-B10","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/s0140-6736(96)90806-5","article-title":"Collaborative Group on Hormonal Factors in Breast C. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"issue":"9609","key":"2022041207582362500_djac006-B11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"2022041207582362500_djac006-B12","doi-asserted-by":"publisher","first-page":"51.e1","DOI":"10.1016\/j.ajog.2021.01.014","article-title":"Oral contraceptive use and ovarian cancer risk for BRCA1\/2 mutation carriers: an international cohort study","volume":"225","author":"Schrijver","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2022041207582362500_djac006-B13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"2022041207582362500_djac006-B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","article-title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","volume":"121","author":"Metcalfe","year":"2019","journal-title":"Br J Cancer"},{"issue":"15","key":"2022041207582362500_djac006-B15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"journal-title":"J Natl Cancer Inst","article-title":"Oral contraceptive use in BRCA1 and BRCA2 mutation carriers: absolute cancer risks and benefits","author":"Schrijver","key":"2022041207582362500_djac006-B16"},{"issue":"7299","key":"2022041207582362500_djac006-B17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature09091","article-title":"Progesterone induces adult mammary stem cell expansion","volume":"465","author":"Joshi","year":"2010","journal-title":"Nature"},{"issue":"7","key":"2022041207582362500_djac006-B18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/cr.2016.69","article-title":"RANKL\/RANK control Brca1 mutation-driven mammary tumors","volume":"26","author":"Sigl","year":"2016","journal-title":"Cell Res"},{"issue":"11","key":"2022041207582362500_djac006-B19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.mayocp.2016.08.002","article-title":"Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study","volume":"91","author":"Rocca","year":"2016","journal-title":"Mayo Clinic Proceedings"},{"issue":"1","key":"2022041207582362500_djac006-B20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ygyno.2018.10.040","article-title":"Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation","volume":"152","author":"Hall","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"8","key":"2022041207582362500_djac006-B21","doi-asserted-by":"publisher","first-page":"e198420","DOI":"10.1001\/jamanetworkopen.2019.8420","article-title":"Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation","volume":"2","author":"Kotsopoulos","year":"2019","journal-title":"JAMA Netw Open"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djac006\/42601393\/djac006.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/4\/483\/43355796\/djac006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/4\/483\/43355796\/djac006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T07:58:49Z","timestamp":1649750329000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/114\/4\/483\/6512065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,1,20]]},"published-print":{"date-parts":[[2022,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djac006","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"type":"print","value":"0027-8874"},{"type":"electronic","value":"1460-2105"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2022,1,20]]}}}